Enzon Pharmaceuticals (Weighted Average Cost of Capital (WACC) Analysis)
 Improve your investment analysis with by seeing the Enzon Pharmaceuticals's Discounted Cash Flow analysis, Enzon Pharmaceuticals's Warren Buffet analysis, and Enzon Pharmaceuticals's Comparable Multiple analysis.  Helpful Information for Enzon Pharmaceuticals's AnalysisWhat is the WACC Formula? Analyst use the WACC Discount Rate (weighted average cost of capital) to determine Enzon Pharmaceuticals's investment risk. WACC Formula = Cost of Equity (CAPM) * Common Equity + (Cost of Debt) * Total Debt. The result of this calculation is an essential input for the discounted cash flow (DCF) analysis for Enzon Pharmaceuticals. Value Investing Importance? This method is widely used by investment professionals to determine the correct price for investments in Enzon Pharmaceuticals before they make value investing decisions. This WACC analysis is used in Enzon Pharmaceuticals's discounted cash flow (DCF) valuation and see how the WACC calculation affect's Enzon Pharmaceuticals's company valuation. |
WACC Analysis Information1. The WACC (discount rate) calculation for Enzon Pharmaceuticals uses comparable companies to produce a single WACC (discount rate). An industry average WACC (discount rate) is the most accurate for Enzon Pharmaceuticals over the long term. If there are any short-term differences between the industry WACC and Enzon Pharmaceuticals's WACC (discount rate), then Enzon Pharmaceuticals is more likely to revert to the industry WACC (discount rate) over the long term. 2. The WACC calculation uses the higher of Enzon Pharmaceuticals's WACC or the risk free rate, because no investment can have a cost of capital that is better than risk free. This situation may occur if the beta is negative and Enzon Pharmaceuticals uses a significant proportion of equity capital. |
